Nelarabine Injection
Product Images NDC 70771-1685

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Nelarabine (NDC 70771-1685). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Vial Label (3fdea8e8 07e5 41bc 964d 34b7a82e24f1 01)

Nelarabine Injection is a medication used for intravenous infusion. It comes in a 50 mL single-dose vial with 250 mg of Nelarabine at a concentration of 5 mg/mL. Each mL contains 4.5 mg of sodium chloride USP for tonicity adjustment, with sodium hydroxide NF and hydrochloric acid NF for pH adjustment. It contains no preservative and vial stoppers are not made with natural rubber latex. This medication is produced in India by Gadila Healthoare Ltd. and should be stored at room temperature (25°C) with excursions between 15°C - 30°C permitted. The usual dosage should be followed as outlined in the package insert.*

FDA Label Image

1's Carton (3fdea8e8 07e5 41bc 964d 34b7a82e24f1 02)

FDA Label Image

6's Carton (3fdea8e8 07e5 41bc 964d 34b7a82e24f1 03)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.